The United States Food and Drug Administration (US FDA) on Friday (November 19) gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the single jab vaccine.
The US Centers for Disease Control was due to meet later Friday (November 19) on a policy recommendation to expand booster shot eligibility to all American adults accordingly – CDC Director Rochelle Walensky was expected to sign off on the recommendation immediately.
Read the full story at Health Policy Watch.
SEE ALSO:
- Pfizer and BioNTech receive expanded U.S. FDA Emergency Use Authorization of COVID-19 vaccine booster to include individuals 18 and older
- Moderna announces FDA authorization of booster dose of COVID-19 vaccine in the U.S. for adults 18 years and older
- U.S. CDC Advisory Committee on Immunization Practices recommends booster vaccination with Moderna’s COVID-19 vaccine
Source : Health Policy Watch
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.